|
|
|
| |
| |
NEW ON THE MARKET
|
| |
Antiarrhythmic drug dronedarone (MULTAQ) for atrial fibrillation
|
| |
| |
REVIEW
|
| |
Fat-modified diet for cardiovascular prevention - what is proven?
|
| |
| |
IN BRIEF
|
| |
UMCKALOABO - patent for manufacturing revoked
Inhibitor ranibizumab (LUCENTIS): erratum
|
| |
| |
SIDE EFFECTS
|
 |
Finally: appetite suppressant sibutramine (REDUCTIL) off market
Progressive multifocal leukencephalopathy (PML) due to natalizumab (TYSABRI)
|
| |
© arznei-telegramm 2/2010
|
|
|  |
|